← Back to headlines
IP Group CEO on 2025 highlights, NAV uplift, Pfizer royalties & capital allocation
The CEO of IP Group provided insights into the company's projected highlights for 2025, including anticipated net asset value uplift, Pfizer royalties, and capital allocation strategies.
16 Mar, 15:38 — 16 Mar, 15:38
Sources
Showing 1 of 1 sources
